CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+8.31%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$5.17B
AUM Growth
+$808M
(+19%)
Cap. Flow
+$413M
Cap. Flow
% of AUM
8%
Top 10 Holdings %
Top 10 Hldgs %
16.85%
Holding
725
New
51
Increased
415
Reduced
155
Closed
32
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
+$45.5M |
| 2 |
Gilead Sciences
GILD
|
+$39.4M |
| 3 |
GE Aerospace
GE
|
+$36.8M |
| 4 |
Motorola Solutions
MSI
|
+$26M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$24.4M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
+$55.4M |
| 2 |
Amgen
AMGN
|
+$30M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$23.3M |
| 4 |
Canadian National Railway
CNI
|
+$21.7M |
| 5 |
Becton Dickinson
BDX
|
+$18.5M |
Sector Composition
| 1 | Healthcare | 24.05% |
| 2 | Financials | 13.76% |
| 3 | Technology | 12.92% |
| 4 | Communication Services | 9.3% |
| 5 | Consumer Staples | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Cigna
CI
$80.6B
| $2.32M | 0.04% |
15,839
+2,672
| +20% | +$391K |
|
402
Xcel Energy
XEL
$42.6B
| $2.31M | 0.04% |
52,013
+12,169
| +31% | +$541K |
|
|
PRTK
403
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $2.31M | 0.04% |
+120,000
| New | +$2.31M |
|
404
Roper Technologies
ROP
$55.9B
| $2.29M | 0.04% |
11,092
+2,820
| +34% | +$582K |
|
|
RDUS
405
DELISTED
Radius Health, Inc.
RDUS
| $2.28M | 0.04% |
59,000
-3,000
| -5% | -$116K |
|
|
ALDR
406
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $2.27M | 0.04% |
109,000
+69,000
| +173% | +$1.44M |
|
407
Principal Financial Group
PFG
$17.8B
| $2.25M | 0.04% |
35,605
+5,289
| +17% | +$334K |
|
408
Intercontinental Exchange
ICE
$99.3B
| $2.25M | 0.04% |
37,492
+7,959
| +27% | +$477K |
|
409
Fortive
FTV
$16.1B
| $2.23M | 0.04% |
44,301
+12,785
| +41% | +$644K |
|
410
Nektar Therapeutics
NKTR
$924M
| $2.23M | 0.04% |
6,333
-5,334
| -46% | -$1.88M |
|
411
Karyopharm Therapeutics
KPTI
$54.9M
| $2.21M | 0.04% |
11,467
-14,533
| -56% | -$2.8M |
|
412
Cognizant
CTSH
$34.6B
| $2.19M | 0.04% |
36,795
+8,357
| +29% | +$497K |
|
413
Shinhan Financial Group
SHG
$23B
| $2.18M | 0.04% |
+52,200
| New | +$2.18M |
|
414
Crown Castle
CCI
$41.2B
| $2.18M | 0.04% |
+23,081
| New | +$2.18M |
|
415
Equinix
EQIX
$76.3B
| $2.18M | 0.04% |
5,433
+1,492
| +38% | +$597K |
|
416
Waters Corp
WAT
$17.9B
| $2.14M | 0.04% |
13,669
+2,717
| +25% | +$425K |
|
417
Acadia Pharmaceuticals
ACAD
$4.19B
| $2.1M | 0.04% |
+61,000
| New | +$2.1M |
|
418
Sun Life Financial
SLF
$32.9B
| $2.09M | 0.04% |
57,358
-223,440
| -80% | -$8.14M |
|
419
Kroger
KR
$44.7B
| $2.08M | 0.04% |
70,616
+12,554
| +22% | +$370K |
|
|
AGEN
420
Agenus
AGEN
$162M
| $2.07M | 0.04% |
27,905
| – | – |
|
421
Paychex
PAYX
$48.3B
| $2.07M | 0.04% |
35,060
+3,298
| +10% | +$194K |
|
422
Fiserv
FI
$74.2B
| $2.06M | 0.04% |
35,764
+7,590
| +27% | +$438K |
|
423
Mettler-Toledo International
MTD
$26.5B
| $2.06M | 0.04% |
4,298
+652
| +18% | +$312K |
|
|
GWPH
424
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $2.06M | 0.04% |
17,000
+3,000
| +21% | +$363K |
|
425
Expeditors International
EXPD
$16.4B
| $2.06M | 0.04% |
36,372
+5,258
| +17% | +$297K |
|